• Aucun résultat trouvé

Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?

N/A
N/A
Protected

Academic year: 2021

Partager "Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance--does the risk of misclassification vary according to biopsy criteria?"

Copied!
12
0
0

Texte intégral

Références

Documents relatifs

Dans cette étude, l’élastographie en temps réel avait une valeur diagnostique haute pour l’identification correcte des lésions cancéreuses dans la prostate. Nos

Les caractéristiques initiales des patients encore en SA à la fin du suivi ont été comparées à celles des patients qui en étaient sortis en analyses uni- et multivariées.. Le

The risk of upstaged disease increases with body mass index in low-risk prostate can- cer patients eligible for

and high risk of disease progression prostate cancer, external beam radiation

Pi- lot trial of adjuvant paclitaxel plus androgen deprivation for patients with high-risk prostate cancer after radical prostatectomy: results on toxicity, side effects

A recent retrospective study, that evaluated the usefulness of 11 C- choline PET/TC in 605 patients with early recurrent pros- tate cancer referred for salvage radiotherapy, showed

The objectives of this study are to quantify changes in PSA testing in Ontario males aged 35 or older from 2003 to 2012, and to study the associa- tion of selected factors,

Given that my father had incidental prostate cancer later in his life, and considering myself to be at some increased risk, I enrolled in the multicentre